RN1701 injection

BIOLOGICAL3 trials

Sponsors

YANRU WANG, Affiliated Hospital of Nantong University, The First Affiliated Hospital with Nanjing Medical University

Conditions

Relapsed/Refractory B-cell Lymphoma

Early Phase 1

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Not yet recruitingNCT07563543

The First Affiliated Hospital with Nanjing Medical UniversityRelapsed/Refractory B-cell Lymphoma

Start: 2026-05-08End: 2028-06-30Target: 10Updated: 2026-05-04

Phase 1

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Not yet recruitingNCT07316920

YANRU WANGRelapsed/Refractory B-cell Lymphoma

Start: 2025-12-22End: 2027-12-31Target: 19Updated: 2026-01-06

RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Not yet recruitingNCT07506668

Affiliated Hospital of Nantong UniversityRelapsed/Refractory B-cell Lymphoma

Start: 2026-03-23End: 2028-05-30Target: 10Updated: 2026-04-02